GYNION, LLC
Menorrx, a drug-device combination using trichloroacetic acid formulation with an innovative delivery system for endometrial ablation to treat heavy menstrual bleeding
- Sector
- Medtech
- Headquarters
- Trumbull, CT
- Founded
- 2016
- Latest Form D
- $391K, Apr 2019
- Total capital
- $1.1M
- Federal grants
- $668K
- 2 awards · 2023–2024
- Rank in peer group#109 of 445
- Private capital raised
- $391K
- 1 Form D · last Apr 2019
- 90 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 5 pending · first 2022
- Rank in peer group#88 of 445
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Development of ablative therapy for the destruction of cervical neoplasia$367K
- Federal grantHealth and Human S · Phase I · Development of an endometrial ablation drug-device combination to treat heavy menstrual bleeding$301K
- Private capital raisedForm D · SEC · 1st filing$391K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 445 peers
Line = medianMedtech · Device
- Federal grants#109 · top 24%
- Granted patents#88 · top 20%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Oleg ShikhmanResearcherExecutive Officer, PromoterLinked by 2 patents · $301K in grants as PI
- Steven R. GoldsteinExecutive Officer, PromoterNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 7- PendingSystem And Method For Delivering Therapeutic Agents To The Uterine CavityUSPTOApplication 18270900
- GrantedSystem And Method For Delivering Therapeutic Agents To The Uterine CavityUSPTOUS 11,813,423
- GrantedSystem And Method For Delivering Therapeutic Agents To The Uterine CavityUSPTOUS 11,511,091
Show all 7 patent records
- System And Method For Delivering Therapeutic Agents To The Uterine CavityOct 30, 2025 · Application 18270900Pending
- System And Method For Delivering Therapeutic Agents To The Uterine CavityNov 14, 2023 · US 11,813,423Granted
- System And Method For Delivering Therapeutic Agents To The Uterine CavityNov 29, 2022 · US 11,511,091Granted
- System And Method For Delivering Therapeutic Agents To The Uterine CavityAug 20, 2020 · Application 16818102Pending
- System And Method For Delivering Therapeutic Agents To The Uterine CavityApplication PCTUS2020022608Pending
- System And Method For Delivering Therapeutic AgentsApplication 63138556Pending
- System And Method For Delivering Therapeutic Agents To The Uterine CavityApplication PCTUS2022012081Pending
Related companies, and why
- GATEWAY BIOTECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
- MicroStructure Imaging, Inc.Similar federal contract value in Medtech · null in contracts
- ENDOTHEIA INCSimilar federal contract value in Medtech · null in contracts
- SCIKON INNOVATION, INC.Similar federal contract value in Medtech · null in contracts
- TGen Tech, LLCSimilar federal contract value in Medtech · null in contracts
- DIATECH DIABETES, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .